Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuxing Liu

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|March 12, 2025
Building a Highly Stable Red/Near Infrared Afterglow Library with Highly Branched StructuresMeng Wang, Xiuxing Liu, Wentao Yuan, et al.
Frontiers in Medicine|January 31, 2022
Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional TherapyShizhao Yang, Tianyu Tao, Zhaohao Huang, et al.
International Immunopharmacology|July 3, 2020
Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitisYingqi Li, Xiuxing Liu, Jianfeng Yu, et al.
International Immunopharmacology|February 13, 2021
Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet's uveitis with vasculitisShizhao Yang, Zhaohao Huang, Xiuxing Liu, et al.
Materials Horizons|September 17, 2021
Multi-photoresponsive triphenylethylene derivatives with photochromism, photodeformation and room temperature phosphorescenceYunhao Fan, Mengmeng Han, Arui Huang, et al.
Biochemical Pharmacology|May 31, 2023
γδ T cells in autoimmune uveitis pathogenesis: A promising therapeutic targetChun Zhang, Xiuxing Liu, Jing Xiao, et al.
Biomolecules|February 7, 2020
Pharmacological Inhibition of Caspase-8 Suppresses Inflammation-Induced Angiogenesis in the CorneaYunzhe Tian, He Li, Xiuxing Liu, et al.
Biochemical Pharmacology|November 30, 2024
An analysis of single-cell data reveals therapeutic effects of AMG487 in experimental autoimmune uveitisLoujing Jiang, Runping Duan, Xiaoyang Yu, et al.
Science Advances|July 16, 2025
Heterochronic parabiosis uncovers AdipoR1 as a critical player in retinal rejuvenationYidan Liu, Xiuxing Liu, Jianjie Lv, et al.
Frontiers in Pharmacology|July 9, 2021
The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal VasculitisShizhao Yang, Zhaohao Huang, Yunwei Hu, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Advanced Materials (Deerfield Beach, Fla.)|March 12, 2025
Building a Highly Stable Red/Near Infrared Afterglow Library with Highly Branched StructuresMeng Wang, Xiuxing Liu, Wentao Yuan, et al.
Frontiers in Medicine|January 31, 2022
Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional TherapyShizhao Yang, Tianyu Tao, Zhaohao Huang, et al.
International Immunopharmacology|July 3, 2020
Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitisYingqi Li, Xiuxing Liu, Jianfeng Yu, et al.
International Immunopharmacology|February 13, 2021
Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet's uveitis with vasculitisShizhao Yang, Zhaohao Huang, Xiuxing Liu, et al.
Materials Horizons|September 17, 2021
Multi-photoresponsive triphenylethylene derivatives with photochromism, photodeformation and room temperature phosphorescenceYunhao Fan, Mengmeng Han, Arui Huang, et al.
Biochemical Pharmacology|May 31, 2023
γδ T cells in autoimmune uveitis pathogenesis: A promising therapeutic targetChun Zhang, Xiuxing Liu, Jing Xiao, et al.
Biomolecules|February 7, 2020
Pharmacological Inhibition of Caspase-8 Suppresses Inflammation-Induced Angiogenesis in the CorneaYunzhe Tian, He Li, Xiuxing Liu, et al.
Biochemical Pharmacology|November 30, 2024
An analysis of single-cell data reveals therapeutic effects of AMG487 in experimental autoimmune uveitisLoujing Jiang, Runping Duan, Xiaoyang Yu, et al.
Science Advances|July 16, 2025
Heterochronic parabiosis uncovers AdipoR1 as a critical player in retinal rejuvenationYidan Liu, Xiuxing Liu, Jianjie Lv, et al.
Frontiers in Pharmacology|July 9, 2021
The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal VasculitisShizhao Yang, Zhaohao Huang, Yunwei Hu, et al.
Pageof 6